Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria
Background: Hematological malignancies, like other cancers, are on the rise. Their treatments have been revolutionized using biological molecules (biologics and biosimilars). These novel agents are used in the care of cancer patients and have significantly improved survival. While biosimilars are wi...
Saved in:
Main Authors: | Rufai A. Dachi, Mustapha S. Umar, Maryam Mahdi, Nura H. Alkali, Falmata G. Mustapha, Fatima M. Muhammad, Alhaji Abdu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-07-01
|
Series: | International Journal of Medicine and Health Development |
Subjects: | |
Online Access: | https://doi.org/10.4103/ijmh.ijmh_33_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
by: Mohammed Alqahtani, et al.
Published: (2024-11-01) -
Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
by: Xiang-mei Wen, et al.
Published: (2025-02-01) -
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
by: Amirata Mohseni, et al.
Published: (2025-01-01) -
Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in patients with hematological malignancies from 2014 to 2022
by: Meng Li, et al.
Published: (2025-01-01) -
Occurrence of Cytomegalovirus among pregnant antenatal women within Bauchi metropolis, Nigeria
by: Timothy Waje, et al.
Published: (2025-03-01)